IQVIA Holdings Inc



+33.1% last 12 months

Market Cap

$48.3 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$170.00 - $285.61

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio


The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $48.3 Billion
Enterprise Value $59 Billion
Dividend Yield $0.00 (0.0%)
1 Year Return +33.1%
52-Week High $285.61
52-Week Low $170.00
Beta 0.96
Outstanding Shares 192 Million
Avg 30 Day Volume 782 Thousand


P/E Ratio 62.97
PEG 39.75
Earnings per Share $3.92
Price to Sales Ratio 3.46
Price to Book Ratio 8.08
Revenue to Enterprise Value 4.36
EBIT to Enterprise Value 47.58
Total Debt to Enterprise Value 0.21
Debt to Equity 2.09


Revenue $13.5 Billion
Gross Profit $4.5 Billion
EBIT $1.24 Billion
Net Income $767 Million
Profit Margin 5.67%
Quarterly Earnings Growth (YoY) +158.4%
Return on Equity 13.16%
Return on Assets 3.19%
Return on Invested Capital 6.46%

Insider trades

No purchases

No sells

No purchases

6,055 shares sold (1 transactions)

10,000 shares bought (1 transactions)

No sells

No purchases

No sells

Q2 2021 Q3 2021 Q4 2021 Q1 2022

About IQVIA Holdings Inc

CEO: Ari Bousbib

Industry: Offices of All Other Miscellaneous Health Practitioners

Similar stocks

Northwest Biotherapeutics Inc
Northwest Biotherapeutics Inc
National Research Corp
National Research Corp
Nymox Pharmaceutical Corp
Nymox Pharmaceutical Corp